FEATURED CONTRIBUTED CONTENT
If you have ever worked with Orphan Drugs, you know finding appropriate patients is a major commercial challenge. Pharmaceutical sponsors of Orphan Drugs often lack the infrastructure and capabilities necessary to identify physicians who diagnose, treat, and manage these rare patients. There are many challenges facing the Orphan Drug category: Multiple healthcare providers and specialties […]
In this episode, Chuck Reed talks about the Elevate Provider Network, how it helps provide better patient care, and how it benefits other stakeholders in the prescription medicine ecosystem.
In this episode, our panel of experts will talk about the state of the rare disease space, and how to succeed in this growing arena. There is also a related white paper on this topic, which you can download using the link at the bottom of this listing.
In this episode, Michael Carlin of TrialCard discusses rare diseases and orphan drugs, and how life sciences companies can overcome the many business challenges associated with these types of disease states. There is also a related white paper entitled “No Patient Left Behind – Connecting Rare Disease Patients to Orphan Drug Manufacturers.” Use the download link […]
Standard for Exchange of Nonclinical Data (SEND) is a new formatting requirement for the submission of electronic data to the FDA. This initiative is led by the Clinical Data Interchange Standards Consortium (CDISC) with the intent to integrate clinical Study Data Tabulation Models (SDTM) into nonclinical data submissions. SEND creates structured organization and terminology for […]
Do men and women trust the biopharmaceutical industry? How do the genders agree and disagree on this topic? The results of two recent surveys paint a concerning picture, yet also show ways the industry can impact these opinions. This analysis reveals how men and women prefer to engage with healthcare organizations and presents a roadmap […]
In less than five years, mHealth has evolved from a futurist’s bold idea to the new normal. Studies are implementing patient- and site-facing apps and reaping the rewards today. We know that mHealth technologies are arrows in a sponsor’s patient-centric quiver – and that strategies that include them see improved engagement, more reliable data and higher retention rates. Yet […]
This new white paper covers how men and women think about the biopharma industry, specifically in the area of trust. The white paper summarizes two surveys that compare and contrast the thoughts of men and women. The findings are quite interesting. Here are some of the highlights. Pharma is ranked below the average industry in terms […]
Cardiovascular outcome studies can be a bit like piloting the Queen Mary – multiple compartments, complex interrelated activities, difficult to launch and bring into port. To commemorate World Heart Day on September 29th, Worldwide Clinical Trial experts will highlight common challenges and key success factors, as well as design and operational conventions in cardiovascular outcome […]
Managing an efficient, well-organized start-up phase is critical to overall study success. While IRB review is just one element of the study start-up process, the IRB can play a crucial role in reaching key study milestones in multisite clinical trials for sponsors, CROs and research sites. By following a few simple steps, you can see […]
Tim Davis, Founder and CEO of Exco InTouch, is a pioneer in the clinical trials technology space. One of the 2016 PharmaVOICE 100, Davis has been busy since founding Exco InTouch in 2004. Here are just a few of the company’s accomplishments under Tim’s leadership: • First to use mobile phones for patient engagement in […]
An estimated 400 million people worldwide are currently living with rare diseases. There are approximately 7,000 different types of rare diseases and disorders, with more being discovered every day. At best, the knowledge base about any individual rare disease is small, fragmented, and often the preserve of a relatively few thought leaders and experts in the field. Moreover, […]
The PharmaVOICE 100 Celebration convenes the most influential and inspirational leaders from across all sectors of the life-sciences industry. PharmaVOICE’s unique positioning allows us to bring together these leaders in a distinctive format allowing for much-needed collaboration through sharing ideas, insights, and business perspectives, while offering the opportunity to expand personal and professional networks. Thursday […]